Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G J Durant

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Bioorganic & Medicinal Chemistry Letters|March 7, 2001
Identification and characterization of a potential ischemia-selective N-methyl-D-aspartate (NMDA) receptor ion-channel blocker, CNS 5788S Padmanabhan, M E Perlman, L Zhang, et al.
Bioconjugate Chemistry|May 1, 1993
N-(3-azidophenyl)-N-methyl-N'-([4-1H]- and [4-3H]-1-naphthyl)guanidine. A potent and selective ligand designed as a photoaffinity label for the phencyclidine site of the N-methyl-D-aspartate receptorK R Gee, G J Durant, D L Holmes, et al.
Journal of Medicinal Chemistry|October 1, 1985
The histamine H2 receptor agonist impromidine: synthesis and structure-activity considerationsG J Durant, C R Ganellin, D W Hills, et al.
Gastroenterology|February 1, 1978
Characterization and development of cimetidine as a histamine H2-receptor antagonistR W Brimblecombe, W A Duncan, G J Durant, et al.
Journal of Medicinal Chemistry|July 1, 1977
Cyanoguanidine-thiourea equivalence in the development of the histamine H2-receptor antagonist, cimetidineG J Durant, J C Emmett, C R Ganellin, et al.
Journal of Medicinal Chemistry|January 1, 1986
Dipole moment in relation to H2 receptor histamine antagonist activity for cimetidine analoguesR C Young, G J Durant, J C Emmett, et al.
Nuclear Medicine and Biology|November 1, 2000
Synthesis and binding characteristics of N-(1-naphthyl)-N'-(3-[(125)I]-iodophenyl)-N'-methylguanidine ([(125)I]-CNS 1261): a potential SPECT agent for imaging NMDA receptor activationJ Owens, A A Tebbutt, A L McGregor, et al.
Annals of the New York Academy of Sciences|September 15, 1995
Neuroprotective use-dependent blockers of Na+ and Ca2+ channels controlling presynaptic release of glutamateS M Goldin, K Subbarao, R Sharma, et al.
Journal of Medicinal Chemistry|April 2, 1993
Design, synthesis, and neurochemical evaluation of 5-(3-alkyl-1,2,4- oxadiazol-5-yl)-1,4,5,6-tetrahydropyrimidines as M1 muscarinic receptor agonistsP G Dunbar, G J Durant, Z Fang, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1995
Pharmacological characterization of GT-2016, a non-thiourea-containing histamine H3 receptor antagonist: in vitro and in vivo studiesC E Tedford, S L Yates, G P Pawlowski, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Bioorganic & Medicinal Chemistry Letters|March 7, 2001
Identification and characterization of a potential ischemia-selective N-methyl-D-aspartate (NMDA) receptor ion-channel blocker, CNS 5788S Padmanabhan, M E Perlman, L Zhang, et al.
Bioconjugate Chemistry|May 1, 1993
N-(3-azidophenyl)-N-methyl-N'-([4-1H]- and [4-3H]-1-naphthyl)guanidine. A potent and selective ligand designed as a photoaffinity label for the phencyclidine site of the N-methyl-D-aspartate receptorK R Gee, G J Durant, D L Holmes, et al.
Journal of Medicinal Chemistry|October 1, 1985
The histamine H2 receptor agonist impromidine: synthesis and structure-activity considerationsG J Durant, C R Ganellin, D W Hills, et al.
Gastroenterology|February 1, 1978
Characterization and development of cimetidine as a histamine H2-receptor antagonistR W Brimblecombe, W A Duncan, G J Durant, et al.
Journal of Medicinal Chemistry|July 1, 1977
Cyanoguanidine-thiourea equivalence in the development of the histamine H2-receptor antagonist, cimetidineG J Durant, J C Emmett, C R Ganellin, et al.
Journal of Medicinal Chemistry|January 1, 1986
Dipole moment in relation to H2 receptor histamine antagonist activity for cimetidine analoguesR C Young, G J Durant, J C Emmett, et al.
Nuclear Medicine and Biology|November 1, 2000
Synthesis and binding characteristics of N-(1-naphthyl)-N'-(3-[(125)I]-iodophenyl)-N'-methylguanidine ([(125)I]-CNS 1261): a potential SPECT agent for imaging NMDA receptor activationJ Owens, A A Tebbutt, A L McGregor, et al.
Annals of the New York Academy of Sciences|September 15, 1995
Neuroprotective use-dependent blockers of Na+ and Ca2+ channels controlling presynaptic release of glutamateS M Goldin, K Subbarao, R Sharma, et al.
Journal of Medicinal Chemistry|April 2, 1993
Design, synthesis, and neurochemical evaluation of 5-(3-alkyl-1,2,4- oxadiazol-5-yl)-1,4,5,6-tetrahydropyrimidines as M1 muscarinic receptor agonistsP G Dunbar, G J Durant, Z Fang, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1995
Pharmacological characterization of GT-2016, a non-thiourea-containing histamine H3 receptor antagonist: in vitro and in vivo studiesC E Tedford, S L Yates, G P Pawlowski, et al.
Pageof 3